openPR Logo
Press release

Dilyx Appoints Distributor in Japan

11-16-2011 10:10 AM CET | Health & Medicine

Press release from: Dilyx Biotechnologies

Dilyx Biotechnologies, LLC is pleased to announce that is has signed an agreement with Funakoshi Co. Ltd. of Japan, to distribute Dilyx’ protein solubility products in that region.

Dave Dilyx, Technical Advisor of Dilyx said: “I am delighted to have secured such an outstanding organization as distributor of our protein solubility products in Japan. Funakoshi has an excellent reputation amongst life scientists in Japan and we have been very impressed by their sales, technology and service capability. This agreement enhances our access to customers, and will significantly reinforce our presence in the Asia region”.
Commenting on the agreement, Dr. Ryoya Funakoshi, President and CEO of Funakoshi Co. Ltd. added: “Dilyx’ innovative product line will be an excellent addition to our current life science portfolio and I am very pleased to have Dilyx Biotechnologies as a partner”.

The fast market acceptance of the OptiSol Protein Solubility Kit in Europe and USA together with the favorable reception of the recently launched OptiResc Protein Aggregate Solubilization Kit has driven the implementation of our strategy for product distribution in Japan.

Dilyx Biotechnologies, LLC is a privately held, Seattle, WA based biotechnology company launching innovative products that help life science researchers to better understand and improve protein sample behavior.

Dave Dilyx, Technical Advisor
Dilyx Biotechnologies, LLC
815 1st Ave
Seattle
WA 98104, USA
dave@dilyx.com

Phone: 425-205-0588
Fax: 202-207-0398
Web: www.dilyx.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dilyx Appoints Distributor in Japan here

News-ID: 200664 • Views:

More Releases from Dilyx Biotechnologies

Dilyx Launches Kit for Improved Protein Solubility
Seattle, WA, 17 November, 2010 - Dilyx Biotechnologies, LLC announces the launch of the OptiSol Protein Solubility Screening Kit, allowing research scientists to aggregation-proof their protein samples. The resulting data saves effort and money because it informs life science researchers on how to best treat specific samples for storage or analysis. Find more information at http://www.dilyx.com/protein-solubilization-kit/ Since protein aggregation is the number one cause of inadvertent protein sample loss, Dilyx’

More Releases for Funakoshi

GALNT1 Antibody Market Upcoming Trends, Top Company Analysis and Forecast by 202 …
" The GALNT1 Antibody global market is thoroughly researched in this report, noting important aspects like market competition, global and regional growth, market segmentation and market structure. The report author analysts have estimated the size of the global market in terms of value and volume using the latest research tools and techniques. The report also includes estimates for market share, revenue, production, consumption, gross profit margin, CAGR, and other key factors.
Artificial Cerebrospinal Fluid Market Global Top Countries Analysis And Opportu …
Worldwide Market Reports released a report on "Global Artificial Cerebrospinal Fluid Market Growth 2022", which covers segment analysis, regional and national level analysis along key players operating in the market. In addition to this, the report also focused on the size, share, trends, and forecast of the market. The report also includes impact analysis along with industry size and revenue. The research report also focused on the drivers, constraints, and
GALNT1 Antibody Market Next Big Thing | Major Market Players are Funakoshi, Cite …
According to a new examination on the GALNT1 Antibody market, a clear state of affairs of the market environment is available, spanning the modern-day and future status of the market. The scope and chance of being profitable, in addition to the producer profile, production details, and intake tendencies, have all been thoroughly researched within the forecast period. They have a look at presents facts on rising traits and market dynamics
MiRNA Kits Market Advancement Strategy, world Top Players | Bio-Rad, BioVendor, …
miRNA purification kits are designed for the isolation of intact microRNA from cells, tissues, or more general RNA preparations. miRNA is small regulatory, non-coding RNA ranging from 20-25 nucleotides. An exclusive MiRNA Kits Market research report has been fabricated through the in depth analysis of the market dynamics across five regions including North America, Europe, South America, Asia-Pacific, Middle East and Africa. The segmentation of the market by components, end users,
miRNA Kits Market Research With Size, Growth, Key Players, Segments And Forecast …
The comprehensive research and analysis report comes out as an incredible and a must-have resource for global miRNA Kits industry players to gain a competitive edge over their opponents. It includes reliable and verified industry size, CAGR, production, consumption, and sales forecasts for the global miRNA Kits industry. It also provides industry revenue and volume estimates for years up to 2026. Readers of the report can easily become aware of
An Extensive Report On Artificial Cerebrospinal Fluid Market 2018 Global Analysi …
Artificial Cerebrospinal Fluid Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. Get FREE Sample Report Before Buying @ https://www.upmarketresearch.com/home/requested_sample/5049 UpMarketResearch offers a latest published report on “Global Artificial Cerebrospinal Fluid Market Analysis and Forecast 2018-2023” delivering key insights and providing a competitive advantage to clients through